TESARO ROE 2011-2018 | TSRO

Current and historical return on equity (ROE) values for TESARO (TSRO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. TESARO ROE for the three months ending September 30, 2018 was -1209.72%.
TESARO ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.65B $-0.13B -1213.08%
2018-06-30 $-0.54B $-0.02B -285.64%
2018-03-31 $-0.52B $0.12B -177.85%
2017-12-31 $-0.50B $0.25B -126.45%
2017-09-30 $-0.45B $0.41B -92.40%
2017-06-30 $-0.51B $0.40B -100.44%
2017-03-31 $-0.42B $0.51B -92.72%
2016-12-31 $-0.37B $0.63B -102.47%
2016-09-30 $-0.31B $0.50B -134.93%
2016-06-30 $-0.29B $0.17B -203.88%
2016-03-31 $-0.29B $0.16B -192.08%
2015-12-31 $-0.25B $0.09B -140.88%
2015-09-30 $-0.23B $0.15B -120.97%
2015-06-30 $-0.19B $0.21B -101.84%
2015-03-31 $-0.17B $0.26B -98.41%
2014-12-31 $-0.17B $0.12B -114.00%
2014-09-30 $-0.15B $0.17B -97.50%
2014-06-30 $-0.14B $0.14B -96.70%
2014-03-31 $-0.12B $0.17B -81.71%
2013-12-31 $-0.09B $0.12B -59.52%
2013-09-30 $-0.09B $0.14B -57.61%
2013-06-30 $-0.07B $0.17B -48.68%
2013-03-31 $-0.07B $0.19B -49.66%
2012-12-31 $-0.06B $0.12B -63.43%
2012-09-30 $-0.04B $0.13B -62.55%
2012-06-30 $-0.03B $0.14B -90.78%
2012-03-31 $-0.01B $0.00B inf%
2011-12-31 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.487B $0.223B
Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer and other cancer indications, and Niraparib, an orally active and potent poly (ADP-ribose) polymerase inhibitor for the treatment of patients with solid tumors. Tesaro, Inc. is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $55.305B 11.85
Zoetis (ZTS) United States $45.369B 31.06
Grifols (GRFS) Spain $14.134B 17.25
Tilray (TLRY) United States $10.566B 0.00
Neurocrine Biosciences (NBIX) United States $9.340B 2060.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.960B 12.86
Ionis Pharmaceuticals (IONS) United States $6.913B 0.00
Nektar Therapeutics (NKTR) United States $6.402B 9.18
Impax Laboratories (AMRX) United States $5.957B 31.68
Sage Therapeutics (SAGE) United States $5.694B 0.00
Catalent (CTLT) United States $5.515B 23.13
Loxo Oncology (LOXO) United States $4.943B 0.00
United Therapeutics (UTHR) United States $4.873B 7.97
Taro Pharmaceutical Industries (TARO) Israel $4.039B 14.96
FibroGen (FGEN) United States $3.347B 0.00
Endo (ENDP) Ireland $2.957B 4.53
USANA Health Sciences (USNA) United States $2.872B 24.44
Madrigal Pharmaceuticals (MDGL) United States $2.871B 0.00
Heron Therapeutics (HRTX) United States $2.149B 0.00
Xencor (XNCR) United States $2.071B 0.00
Aerie Pharmaceuticals (AERI) United States $2.030B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.987B 268.56
Endocyte (ECYT) United States $1.933B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.726B 0.00
PTC Therapeutics (PTCT) United States $1.632B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.487B 18.18
Zogenix (ZGNX) United States $1.465B 0.00
Corcept Therapeutics (CORT) United States $1.463B 21.48
Theravance Biopharma (TBPH) Cayman Islands $1.419B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.376B 0.00
Portola Pharmaceuticals (PTLA) United States $1.356B 0.00
Esperion Therapeutics (ESPR) United States $1.348B 0.00
Tricida (TCDA) United States $1.193B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.129B 0.00
TherapeuticsMD (TXMD) United States $1.120B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.784B 0.00
Radius Health (RDUS) United States $0.684B 0.00
Karyopharm Therapeutics (KPTI) United States $0.651B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.635B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
GlycoMimetics (GLYC) United States $0.528B 0.00
Collegium Pharmaceutical (COLL) United States $0.527B 0.00
ChemoCentryx (CCXI) United States $0.473B 37.44
Dova Pharmaceuticals (DOVA) United States $0.467B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.455B 0.00
Odonate Therapeutics (ODT) United States $0.451B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.450B 0.00
Xeris Pharmaceuticals (XERS) United States $0.448B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Dermira (DERM) United States $0.441B 0.00
ArQule (ARQL) United States $0.434B 0.00
OptiNose (OPTN) United States $0.427B 0.00
Aquestive Therapeutics (AQST) United States $0.415B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.406B 23.90
Siga Technologies (SIGA) United States $0.396B 0.00
Forty Seven (FTSV) United States $0.395B 0.00
Zafgen (ZFGN) United States $0.387B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.377B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.360B 0.00
Mast Therapeutics (SVRA) United States $0.346B 0.00
Depomed (ASRT) United States $0.344B 12.81
Minerva Neurosciences (NERV) United States $0.328B 0.00
KalVista Pharmaceuticals (KALV) United States $0.318B 0.00
Tapimmune (MRKR) United States $0.315B 0.00
Aratana Therapeutics (PETX) United States $0.309B 0.00
Aclaris Therapeutics (ACRS) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.285B 0.00
Majesco Entertainment (PTE) United States $0.281B 0.00
CASI Pharmaceuticals (CASI) United States $0.279B 0.00
Translate Bio (TBIO) United States $0.270B 0.00
IMV INC (IMV) Canada $0.243B 0.00
Affimed (AFMD) Germany $0.240B 0.00
ElectroCore (ECOR) United States $0.237B 0.00
Opexa Therapeutics (ACER) United States $0.235B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.231B 0.00
MEI Pharma (MEIP) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Lannett Co Inc (LCI) United States $0.215B 1.88
Aldeyra Therapeutics (ALDX) United States $0.215B 0.00
Tyme Technologies (TYME) United States $0.212B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.201B 0.00
Galectin Therapeutics (GALT) United States $0.198B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.194B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.193B 0.00
Calithera Biosciences (CALA) United States $0.192B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Neon Therapeutics (NTGN) United States $0.185B 0.00
Ardelyx (ARDX) United States $0.183B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.169B 0.00
ContraFect (CFRX) United States $0.168B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.165B 0.00
Molecular Templates (MTEM) United States $0.162B 0.00
MediWound (MDWD) Israel $0.154B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.152B 0.00
Recro Pharma (REPH) United States $0.150B 0.00
DURECT (DRRX) United States $0.148B 0.00
Melinta Therapeutics (MLNT) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Adherex Technologies (FENC) United States $0.135B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.124B 0.00
ProNAi Therapeutics (SRRA) Canada $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.110B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.109B 0.00
Rafael Holdings (RFL) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.101B 0.00
CTI BioPharma (CTIC) United States $0.097B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.095B 0.00
Achaogen (AKAO) United States $0.092B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.090B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Iterum Therapeutics (ITRM) Ireland $0.080B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.072B 0.00
Nivalis Therapeutics (ALPN) United States $0.072B 0.00
Natural Alternatives (NAII) United States $0.070B 7.87
Immune Design (IMDZ) United States $0.066B 0.00
Forward Pharma (FWP) Denmark $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 39.48
Actinium Pharmaceuticals (ATNM) United States $0.063B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Capnia (SLNO) United States $0.046B 0.00
Avenue Therapeutics (ATXI) United States $0.044B 0.00
Trillium Therapeutics (TRIL) Canada $0.043B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.88
Lipocine (LPCN) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Onconova Therapeutics (ONTX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Biomerica (BMRA) United States $0.025B 0.00
NanoViricides (NNVC) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 7.05
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Aradigm (ARDM) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 1.65
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00